LivaNova PLC (LIVN) has released an update to notify the public and investors about its officers.
LivaNova PLC has appointed Vladimir A. Makatsaria as the new CEO and board member starting March 1, 2024. Makatsaria brings extensive experience from Johnson & Johnson, where he held several executive roles, most notably as Company Group Chairman at J&J MedTech. His compensation includes a $930,000 base salary, potential bonuses, long-term equity awards, and relocation benefits. William A. Kozy will step down as Interim CEO but remain Board Chair. Makatsaria’s hiring involves no family ties or undisclosed transactions with the company.
For further insights into LIVN corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.
